|
1
|
Demuth T and Berens ME: Molecular
mechanisms of glioma cell migration and invasion. J Neurooncol.
70:217–228. 2004. View Article : Google Scholar
|
|
2
|
Omuro A and DeAngelis LM: Glioblastoma and
other malignant gliomas: A clinical review. JAMA. 310:1842–1850.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kohler BA, Ward E, McCarthy BJ, et al:
Annual report to the nation on the status of cancer, 1975–2007,
featuring tumors of the brain and other nervous system. J Natl
Cancer Inst. 103:714–736. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Crocetti E, Trama A, Stiller C, et al:
RARECARE working group: Epidemiology of glial and non-glial brain
tumours in Europe. Eur J Cancer. 48:1532–1542. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stupp R, Mason WP, van den Bent MJ, et al
European Organisation for Research and Treatment of Cancer Brain
Tumour and Radiotherapy Groups: National Cancer Institute of Canada
Clinical Trials Group: Radiotherapy plus concomitant and adjuvant
temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stein U, Walther W, Arlt F, et al: MACC1,
a newly identified key regulator of HGF-MET signaling, predicts
colon cancer metastasis. Nat Med. 15:59–67. 2009. View Article : Google Scholar
|
|
7
|
Chundong G, Uramoto H, Onitsuka T, et al:
Molecular diagnosis of MACC1 status in lung adenocarcinoma by
immunohistochemical analysis. Anticancer Res. 31:1141–1145.
2011.PubMed/NCBI
|
|
8
|
Shimokawa H, Uramoto H, Onitsuka T, et al:
Overexpression of MACC1 mRNA in lung adenocarcinoma is associated
with postoperative recurrence. J Thorac Cardiovasc Surg.
141:895–898. 2011. View Article : Google Scholar
|
|
9
|
Shirahata A, Fan W, Sakuraba K, et al:
MACC 1 as a marker for vascular invasive hepatocellular carcinoma.
Anticancer Res. 31:777–780. 2011.PubMed/NCBI
|
|
10
|
Zhang R, Shi H, Chen Z, Wu Q, Ren F and
Huang H: Effects of metastasis-associated in colon cancer 1
inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells.
J Exp Clin Cancer Res. 30:832011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shirahata A, Sakata M, Kitamura Y, et al:
MACC 1 as a marker for peritoneal-disseminated gastric carcinoma.
Anticancer Res. 30:3441–3444. 2010.PubMed/NCBI
|
|
12
|
Stein U, Smith J, Walther W and Arlt F:
MACC1 controls Met: What a difference an Sp1 site makes. Cell
Cycle. 8:2467–2469. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sheng XJ, Li Z, Sun M, et al: MACC1
induces metastasis in ovarian carcinoma by upregulating hepatocyte
growth factor receptor c-MET. Oncol Lett. 8:891–897.
2014.PubMed/NCBI
|
|
14
|
Yang T, Kong B, Kuang YQ, et al:
Overexpression of MACC1 protein and its clinical implications in
patients with glioma. Tumour Biol. 35:815–819. 2014. View Article : Google Scholar
|
|
15
|
Hagemann C, Fuchs S, Monoranu CM, et al:
Impact of MACC1 on human malignant glioma progression and patients'
unfavorable prognosis. Neuro Oncol. 15:1696–1709. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chai H and Yang Y: Effects of MACC1 siRNA
on biological behaviors of HeLa. Arch Gynecol Obstet.
289:1271–1280. 2014. View Article : Google Scholar
|
|
17
|
Gao J, Ding F, Liu Q and Yao Y: Knockdown
of MACC1 expression suppressed hepatocellular carcinoma cell
migration and invasion and inhibited expression of MMP2 and MMP9.
Mol Cell Biochem. 376:21–32. 2013. View Article : Google Scholar
|
|
18
|
Chen D, Wang Y, Zhang K, Jiao X, Yan B and
Liang J: Antisense oligonucleotide against clusterin regulates
human hepatocellular carcinoma invasion through transcriptional
regulation of matrix metalloproteinase-2 and e-cadherin. Int J Mol
Sci. 13:10594–10607. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Arlt F and Stein U: Colon cancer
metastasis: MACC1 and Met as metastatic pacemakers. Int J Biochem
Cell Biol. 41:2356–2359. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shirahata A, Shinmura K, Kitamura Y, et
al: MACC1 as a marker for advanced colorectal carcinoma. Anticancer
Res. 30:2689–2692. 2010.PubMed/NCBI
|
|
21
|
Meng F, Li H, Shi H, et al: MACC1
down-regulation inhibits proliferation and tumourigenicity of
nasopharyngeal carcinoma cells through Akt/β-catenin signaling
pathway. PloS One. 8:e608212013. View Article : Google Scholar
|
|
22
|
Hunt T: Maturation promoting factor,
cyclin and the control of M-phase. Curr Opin Cell Biol. 1:268–274.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Resnitzky D and Reed SI: Different roles
for cyclins D1 and E in regulation of the G1-to-S transition.
Molecular and Cellular Biol. 15:3463–3469. 1995.
|
|
24
|
Spruck CH, Won KA and Reed SI: Deregulated
cyclin E induces chromosome instability. Nature. 401:297–300. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Velpula KK, Dasari VR, Tsung AJ, et al:
Regulation of glioblastoma progression by cord blood stem cells is
mediated by downregulation of cyclin D1. PloS One. 6:e180172011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Z, Fan M, Candas D, et al: Cyclin
B1/Cdk1 coordinates mitochondrial respiration for cell-cycle G2/M
progression. Dev Cell. 29:217–232. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Adams JM: Ways of dying: Multiple pathways
to apoptosis. Genes Dev. 17:2481–2495. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Adams JM and Cory S: The Bcl-2 apoptotic
switch in cancer development and therapy. Oncogene. 26:1324–1337.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Reed JC: Drug insight: Cancer therapy
strategies based on restoration of endogenous cell death
mechanisms. Nat Clin Pract Oncol. 3:388–398. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kouri FM, Jensen SA and Stegh AH: The role
of Bcl-2 family proteins in therapy responses of malignant
astrocytic gliomas: Bcl2L12 and beyond. ScientificWorldJournal.
2012:8389162012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Renault TT, Teijido O, Antonsson B, Dejean
LM and Manon S: Regulation of Bax mitochondrial localization by
Bcl-2 and Bcl-x(L): Keep your friends close but your enemies
closer. Int J Biochem Cell Biol. 45:64–67. 2013. View Article : Google Scholar
|
|
32
|
Ju H, Li X, Li H, et al: Mediation of
multiple pathways regulating cell proliferation, migration, and
apoptosis in the human malignant glioma cell line U87MG via
unphosphorylated STAT1: Laboratory investigation. J Neurosurg.
118:1239–1247. PubMed/NCBI
|
|
33
|
Ley R, Ewings KE, Hadfield K and Cook SJ:
Regulatory phosphorylation of Bim: Sorting out the ERK from the
JNK. Cell Death Differ. 12:1008–1014. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang G, Kang MX, Lu WJ, Chen Y, Zhang B
and Wu YL: MACC1: A potential molecule associated with pancreatic
cancer metastasis and chemoresistance. Oncol Lett. 4:783–791.
2012.PubMed/NCBI
|
|
35
|
Price JT and Thompson EW: Mechanisms of
tumour invasion and metastasis: Emerging targets for therapy.
Expert J Opin Ther Targets. 6:217–233. 2002. View Article : Google Scholar
|
|
36
|
Boardman LA: Overexpression of MACC1 leads
to downstream activation of HGF/MET and potentiates metastasis and
recurrence of colorectal cancer. Genome Med. 1:362009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kokoszyńska K, Kryński J, Rychlewski L and
Wyrwicz LS: Unexpected domain composition of MACC1 links MET
signaling and apoptosis. Acta Biochim Pol. 56:317–323. 2009.
|
